Wednesday, July 8, 2026

pharma · Primary Mitochondrial Myopathy · Advanced Solid Tumors, Advanced Breast Cancer · OKUR

OnKure Therapeutics

OnKure Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Boulder, USA HQ
2011 Founded
42 Employees
Public company Type
OKUR · NYSE Ticker
Company details
Status
Public
HQ
Boulder, USA
Founded
2011
Employees
42
Programs
8
Drugs
4
Patents
7
Intelligence · Clinical Trials

OnKure Therapeutics clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to OnKure Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

OnKure Therapeutics trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for OnKure Therapeutics.

  1. OKI-219-101 — Phase 1

    Clinical update
  2. Low Dose REN001 — Phase 1

    Clinical update
  3. REN001 — Phase 3

    Clinical update
  4. Mavodelpar — Phase 2

    Clinical update
  5. OKI-179 + binimetinib — Phase 2

    Clinical update
  6. OKI-179 — Phase 1

    Clinical update
  7. OKI-219 — Phase 1

    Clinical update
  8. REN001 — Phase 1

    Clinical update

Trial registry

9 studies